EMILY BLAKE: Open Payments
NPI 1760130355 · FORSYTH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 35 payments from 16 companies in 2025. Trend: 2023 $682 · 2024 $733 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| Globus Medical, Inc. | 2 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Lilly USA, LLC | 3 | $58 |
| INTUITIVE SURGICAL, INC. | 1 | $43 |
| ABBVIE INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
| Astellas Pharma US Inc | 1 | $31 |
| Astellas Pharma Global Development | 1 | $23 |
Products named: AIRSUPRA, Senza, FARXIGA, REXULTI, Da Vinci Surgical System, MOUNJARO, Ozempic, BREZTRI.
Industry payments across MO — which companies pay providers there.
